https://www.selleckchem.com/products/lw-6.html
Rates of BPH/LUTS medication use following transurethral prostatectomy are considerable. Rates of BPH/LUTS medication use after transurethral resection of the prostate varied from 15% to 55%, and discontinuation rates were 54-95% across medications and follow-up periods. For laser prostatectomy, approximately 18% of patients continued medications postoperatively and discontinuation rates ranged from 53% to 75%. Minimal data on holmium laser enucleation existed. For reference, medication discontinuation rates after transurethral needle abla
Me gusta
Comentario
Compartir
